RECRUITINGOBSERVATIONAL
Chinese Alliance for Type 1 Diabetes Multi-center Collaborative Research
About This Trial
The China Alliance for Type 1 Diabetes (CAT1D) is committed to exploring and implementing the model of graded diagnosis and treatment of type 1 diabetes and comprehensive management of outpatient service, carrying out a series of educational activities for patients, and cooperating in the development of multi-center prospective clinical research on type 1 diabetes.
Who May Be Eligible (Plain English)
Who May Qualify:
- Individuals diagnosed with Type 1 Diabetes according to the 1999 World Health Organization report
- Written willing to sign a consent form from the patient or family representative;
- Individuals who own smartphone and are capable of using wechat or apps
Who Should NOT Join This Trial:
- Non-t1dm patients with autoimmune polyendocrine adenopathy syndrome (APS) are the first disease
- With mental disorders
- Have any other condition or disease that may hamper from compliance with the protocol or complication of the trial
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Individuals diagnosed with Type 1 Diabetes according to the 1999 World Health Organization report
* Written informed consent from the patient or family representative;
* Individuals who own smartphone and are capable of using wechat or apps
Exclusion Criteria:
* Non-t1dm patients with autoimmune polyendocrine adenopathy syndrome (APS) are the first disease
* With mental disorders
* Have any other condition or disease that may hamper from compliance with the protocol or complication of the trial
Locations (1)
Institute of Metabolism and Endocrinology, Second Xiangya Hospital, Central South University
Changsha, Hunan, China